TerminatedInterventionalPhase 2Last updated Apr 21, 2014

Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Recombinant Human Erythropoietin (Epoetin Alfa (PROCRIT®)) on Functional Outcomes in Anemic, Critically Ill, Trauma Subjects

Overview

ClinicalTrials.gov ID: NCT00210626
Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY
Brief Summary: The purpose of this trial is to evaluate the physical function outcomes in anemic, critically ill, trauma subjects treated with epoetin alfa (PROCRIT®) compared to placebo.
Study Type: Interventional

Secondary IDs

LTTO;Other Identifier

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Long Term Treatment Outcomes;Other Identifier

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

PR04-15-001Other Identifier

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Status

Overall Status: Terminated
Start Date: Aug 2005
Primary Completion Date: Jun 2008Actual
Completion Date: Jun 2008Actual

Study Record Dates

First Submitted: Sep 13, 2005
First Submitted that Met QC Criteria: Sep 13, 2005
First Posted: Sep 21, 2005Estimated
Last Update Submitted that Met QC Criteria: Apr 2, 2014
Last Update Posted: Apr 21, 2014Estimated
Last Verified: Apr 2014

NCT00210756Completed

Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.

NCT00210834Completed

An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.

NCT00236405Terminated

PROCRIT and Short-Term Outcomes in Orthopedic Surgery

NCT00641589Completed

A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

NCT00091910Completed

Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)

NCT00210795Terminated

A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia